Home / Cancer and immune system / Abatacept
ATC L04AA24 · Selective Immunosuppressants · updated 6 Nov 2026
Abatacept shortage
As of 6 Nov 2026, Abatacept has a reported shortage in 1 of the 16 countries we track (Sweden), covering 1 product from 1 company.
Is there an Abatacept shortage?
Yes. As of 6 Nov 2026, Abatacept is reported short in 1 of the 16 countries we track: Sweden. The earliest expected return is 18 Dec 2026 (Sweden).
Which companies are short
products short, all countriesListed: Bristol Myers Squibb BMY · NYSE
Compared with similar medicines
ATC group L04AA · Selective ImmunosuppressantsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | ORENCIA 125 mg Förfylld penna, 4 st anticipated | Bristol-Myers Squibb Pharma EEIG | 30 Nov 2026 | 18 Dec 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Abatacept shortage?
Yes. As of 6 Nov 2026, Abatacept is reported short in 1 of the 16 countries we track: Sweden. The earliest expected return is 18 Dec 2026 (Sweden).
When will Abatacept be back in stock?
Companies expect supply back from 18 Dec 2026 in Sweden; Sweden: 18 Dec 2026. These are company estimates reported to each authority.
Why is Abatacept in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Abatacept shortages?
Bristol Myers Squibb.